We analysed whole blood and nasopharyngeal swabs from COVID-19 patients in two different cohorts collected at hospitals in Germany (Bochum) and Spain (Valencia) by epigenetic immune cell quantification using qPCR assays (demethyl-specific). The aim was to investigate the prognostic potential of this approach to identify patients with higher risk for a poor outcome. Also, we compared epigenetic data of patients with those of healthy donors.
Dataset includes Cp (crossing-point) values, cell specific plasmid units...